FDAAA serves FDA alumni by providing communications, holding functions, listing opportunities, and much more. Serving those who have served also takes the form of helping those who still are serving, the current staff at FDA.
Welcome to the Food and Drug Administration Alumni Association (FDAAA) website
It has been almost a year since I assumed the role of President of the Association. A year filled with great accomplishments and many activities for members to take part in. It has included a number of luncheons with key Agency managers, the annual luncheon with the Commissioner and her top staff, and a gala reception in celebration of the 75th Anniversary of the FD&C Act to mention a few. We even held our first "Outside the Beltway" reception in Boston to allow "field" members to get further involved. [more]
FDAAA Luncheon with FDA Associate Commissioner for Regulatory Affairs Melinda Plaisier, February 6, 2014
FDAAA's February 6th luncheon was held at a new and very nice venue -- Eggspectation in downtown Silver Spring. Melinda K. Plaisier, Associate Commissioner for Regulatory Affairs (ORA) was the very enlightening and dynamic luncheon speaker, Mrs. Plaisier said that ORA was the backbone of the organization. She said she spent the last couple of weeks visiting many of FDA's import operations and she is always inspired by the employees. They are highly motivated, take great pride in their work, and are proud to be working for FDA and protecting public health.
FDA Chief of Staff Lisa Barclay, J.D. was the speaker at FDAAA's first luncheon of 2014, held at Hogan Lovells in Washington, DC. As Chief of Staff, Ms. Barclay provides integrated policy analysis and strategic consultation to the Commissioner and senior FDA officials on significant Agency issues and programs; provides leadership, coordination and management of the Commissioner's priority policies and issues; and serves as the Agency's principal liaison with HHS.
FDAAA in Johannesburg, South Africa, December 2-3, 2013. Representing the FDAAA International Network, Ekopimo Ibia, MD, MPH (founding member of FDAAAIN and Director, Regulatory Affairs at Merck & Co., Inc.) spoke at the First Biennial Scientific Conference on Medicines Regulation in Africa held December 2-3, 2013 in Johannesburg, South Africa. With the title "Intersection of Public Policy and Regulatory Science: US and EU Efforts to Address Unmet Medical Needs from Serious Bacterial and Neglected Tropical Diseases," Dr. Ibia's talk briefly discussed the growing spread of antibiotic resistant bacteria across the world and also reminded participants that while significant progress has been made, the burden of neglected tropical diseases remains huge.
On December 3, the FDAAA held an end of the year event celebrating the 75th Anniversary of the Federal Food, Drug, and Cosmetic Act (FFDCA). Space for the event was provided by the law firm of Alston and Bird in Washington, DC. Thanks to the law firm and the efforts of Nancy Myers and Anne Marie Finley, FDAAA Activities Committee Co-chairs, the venue was nicely decorated for this seasonal event. There was plenty of delicious food and drink and time to share FDA memories and happenings. Although this event came together quickly, almost 40 FDA friends were able to join in the celebration.
On February 26, 2014, FDA's Center for Radiological Health (CDRH) is holding a memorial seminar for Dr. Janusz Beer, FDAAA member, colleague, and friend in CDRH's Office of Science and Engineering Laboratories. Dr. Beer passed away on October 17, 2013. The memorial seminar is being held at the FDA White Oak Campus from 9:00 am - 4:00 pm. if you plan to attend, please notify Gail Matson (email@example.com) as soon as possible.
FDA Chief Scientist Dr. Jesse Goodman Leaves FDA, Dr. Stephen Ostroff Becomes Acting Chief Scientist
FDA Chief Scientist Dr. Jesse Goodman has left FDA to return to academia and clinical medicine. Commissioner Hamburg stated that "As FDA's Chief Scientist, Dr. Goodman has been a strong voice for both our regulatory science enterprise, and for FDA's role in U.S. and global public health. Among his many accomplishments as Chief Scientist is the development of FDA's Medical Countermeasure Initiative, which has better positioned FDA to play a strong role in building the nation's emergency medical counter measures capacity."
On January 11, 2014, Dr. Murray Lumpkin, Special Advisor to Dr. Hamburg, retired from FDA after a little more than 24 years of service at FDA. He recently served as deputy commissioner for International and Special Programs. In his farewell message, Dr. Lumpkin stated that his time at FDA was "a wonderfully fulfilling professional and personal experience at one of the world's great institutions." He continued to say that he strongly believes "that regulatory authorities are premier platforms for significant engagements related to medical products and food safety and their impact on public health and on the lives of patients and those caring for them. Knowing that each day you get to be a part of such meaningful work with teams of dedicated, bright, passionate people, both at FDA and around the world, whose actions are influencing global public health, is both humbling and rewarding…"
FDA Deputy Commissioner for Foods and Veterinary Medicine, Michael R. Taylor, J.D., has announced that RADM Linda Tollefson, D.V.M., Associate Commissioner for Foods and Veterinary Medicine will retire effective March 1, 2014.
Dr. Hamburg announced the appointment of Howard Sklamberg as Deputy Commissioner for Global Regulatory Operations and Policy, effective January 13, 2014.
Over recent years, globalization, scientific innovation, the increasing breadth and complexity of the products that we regulate, and groundbreaking legislation have created great challenges and opportunities for us. We are rising to these challenges in many ways, including making our decisions more risk based, increasing specialization and the vertical integration of our programs, deepening our collaboration with our global and state regulatory partners, and implementing our new authorities. The Office of Global Regulatory Operations and Policy, which consists of the Office of Regulatory Affairs and the Office of International Programs, will be vital to implementing these changes. I am confident that Howard will provide the strong leadership needed for the Office of Global Regulatory Operations and Policy to seize these opportunities and advance our mission to promote and protect the public health.
I am deeply saddened to announce that John M. Taylor, Counselor to the Commissioner and Acting Deputy Commissioner for Global Regulatory Operations and Policy (GO), will be leaving the Food and Drug Administration in January 2014 to pursue other opportunities. John has accomplished so much during his two stints at the Agency (from 1991 to 2005 and from 2009 to present) as he served in various ways and touched many lives. From his early days in the Office of Chief Counsel, to his senior roles in the Center for Drug Evaluation and Research, the Office of Regulatory Affairs, and the Office of the Commissioner, John has brought leadership, sound advice, and most of all, good humor to his work. We will all miss his expert knowledge, his innovative thinking, and his uncanny ability to remain calm during times of adversity and matters of urgency. John has proven himself as a leader who epitomizes integrity, dignity, kindness and compassion, and he is widely respected by his colleagues.
The Food and Drug Administration has been very fortunate to have had the experience, talent, and dedication of Virginia Cox at the helm of the agency's communications efforts for the past two and a half years. It is therefore difficult for me to share that Virginia will be leaving the Agency in January 2014 to pursue other opportunities.
As Associate Commissioner for External Affairs, Virginia brought a renewed energy to FDA's outreach and communications efforts. Virginia understood the need to communicate clearly, confidently, and concisely to the American public so that consumers can make better and more informed decisions. She also led and implemented a reorganization of the Office of External Affairs to better meet this goal.
NAPPSA's New President and FDAAA Member, Dr. Funmi Ajayi, will Ensure Organization "Continues To Soar on… Like An Eagle"
FDAAA International Network (FDAAAIN) member Funmi Ajayi was elected President of the Nigerian Association of Pharmacists and Pharmaceutical Scientists of the Americas this past September 2013 in Philadelphia, PA. FDAAAIN interviewed Dr. Ajayi about her new role and would like to share her vision of leadership and direction.
Recent FDAAA Events
- FDAAA Luncheon with FDA Associate Commissioner for Regulatory Affairs Melinda Plaisier, February 6, 2014 (02/12/14)
- FDAAA Luncheon with FDA Chief of Staff Lisa Barclay, January 10, 2014 (01/22/14)
- Imo Ibia Spoke in South Africa, December 2013 (12/27/13)
- FDAAA End of 2013 Event Celebrates 75th Anniversary of FFDCA (12/11/13)
- Tom Abrams, Director Office of Prescription Drug Promotion was the speaker at the FDAAA November luncheon held at Mrs. K's Tollhouse on November 13, 2013. (11/21/13)
- Commissioner's Fall Fling Event (10/23/13)
- The "Spring Fling" Turns into the "Fall Fling"; The Frances O. Kelsey Award Finds Permanent Home at FDA Headquarters (10/22/13)
- FDAAA Co-sponsors Workshop on Regulatory Harmonization for Consumer Products in Sub-Saharan Africa, Lagos and Nigeria, July 8, 2013 (08/14/13)
- FDAAA Sponsors US DIA Session on Health Disparities and Global Trials Data (07/21/13)
- Medical Devices Global Symposium (07/20/13)
- FDAAA Holds Its First "Out-side the Beltway" Event in Boston (06/27/13)
- New Chairman for the Nominating Committee (06/14/13)
- CDRH Holding Memorial Seminar on February 26 (02/18/14)
- FDA Chief Scientist Dr. Jesse Goodman Leaves FDA, Dr. Stephen Ostroff Becomes Acting Chief Scientist (02/12/14)
- Special Advisor to Dr. Hamburg Dr. Murray Lumpkin Retires (02/12/14)
- Associate Commissioner for Foods and Veterinary Medicine, Linda Tollefson to Retire (01/31/14)
- Dr. Hamburg announced the appointment of Howard Sklamberg as Deputy Commissioner for Global Regulatory Operations and Policy, effective January 13, 2014. (01/23/14)
- FDA Commissioner Margaret Hamburg announced the resignation of John Taylor (12/28/13)
- FDA Commissioner Margaret Hamburg announced the resignation of Virginia Cox (12/28/13)
- NAPPSA's New President and FDAAA Member, Dr. Funmi Ajayi, will Ensure Organization "Continues To Soar on… Like An Eagle" (09/27/13)
- Melinda Plaisier Named Associate Commissioner for Regulatory Affairs (09/5/13)
This individual page is maintained by Linda Tukenmez